The concentration of IL-13, TGF-β1, and periostin might be the potential predictive biomarkers of occurrence of HF in CAD patients, which can provide new ideas for the treatment of CAD patients with HF clinically. The gene discussed is TGFB1; the disease is hydrops fetalis.